Skip to main content

Table 2 Preclinical advances in scaffold-based stem cell therapy in the last 5 years

From: Meniscus repair: up-to-date advances in stem cell-based therapy

Injury model

Animal

Cell source

Cell density

Scaffold

Stimuli

Duration

Year/References

Punch defect in the lateral meniscus with early osteoarthritis

Rabbit

BMSCs and meniscal cells

1.0 × 106

Collagen–hyaluronan

–

12 weeks

2017/[99]

Full-thickness defect

Rat

BMSCs

5.0 × 105

Decellularized meniscus extracellular matrix

–

2 months

2020/[100]

Full-thickness meniscus defect

Rat

BMSCs

7.5 × 105

Decellularized meniscus extracellular matrix

–

4 weeks

2018/[101]

Meniscectomy

Rabbit

BMSCs

5.0 × 106

3D-printed Poly(e-caprolactone) (PCL)

–

24 weeks

2017/[104]

Punch defects

Rabbit

BMSCs

4.0 × 106

Thermosensitive, injectable, in situ crosslinked hydrogel

TGF-β1

8 weeks

2020/[105]

Punch defects

Rabbit

BMSCs

1.0 × 106

Kartogenin-platelet-rich plasma gel

Kartogenin and platelet

3 months

2019/[106]

Radial defects (5 mm width)

Rabbit

SMSCs

1.6 × 106

Aligned electrospun nanofibrous

–

12 weeks

2018/[108]

Punch defects

Rabbit

ADSCs

4.0 × 105

Polycaprolactone/silk/fibroin/gelatin/ascorbic acid composite

–

2 months

2021/[110]

Full-thickness radial tear spanning 90% of the medial meniscal width

Goat

ADSCs

2.0 × 106

Methacrylated gelatin hydrogel

TGF-β3

6 months

2019/[112]

Unilateral total medial meniscectomy

Rabbit

ADSCs and chondrocytes

2 × 104

Polyvinyl alcohol/Chitosan

–

7 months

2017/[113]

Full-thickness cylindrical defects (diameter = 1.5 mm)

Rabbit

Tonsil-derived mesenchymal stem cells

1.5 × 105

Riboflavin-induced photocrosslinked collagen–hyaluronic acid hydrogel

TGF-β1

10 weeks

2017/[117]

Meniscectomy

Rat

Tendon-derived stem cells and SMSCs

–

Decellularized semitendinosus tendon

–

24 weeks

2017/[118]

Avascular meniscal tear

Sheep

BMSCs

3.0 × 105

Collagen

–

13 weeks

2017/[119]